Clinical Trial: Determination of Prevalence and Features of HRRm mCRPC (ADAM)

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT04712890) titled 'Determination of Prevalence and Features of HRRm mCRPC (ADAM)' on Jan. 8.

Brief Summary: Study design:

This study is local, multi-center, prospective, cohort study to collect real world data related mCRPC patients, prevalence of HRRm and to assess possible influence of HRRm on treatment outcomes. No additional procedures besides those already used in the routine clinical practice will be applied to the patients. Treatment assignment will be done according to the current practice.

Data Source(s):

For testing archival samples (formalin fixed and paraffin embedded [FFPE]) from primary tumor will be used . 15 HRR genes (BRCA1, BRCA2,...